Literature DB >> 511363

Experimental evidence of a decreased incidence of penicillin allergy through use of pure penicillins.

S Ahlstedt, A Kristofferson.   

Abstract

The results revealed the presence of high molecular weight impurities in commercially available penicillins, measured with a radioimmuno assay. The impurities had penicilloyl specificity and induced antibody formation in mice when the contaminated penicillin was administered in 50 mg/kg body weight daily for ten day periods with a 20 to 30 day interval. Penicillin of high purity similarly administered produced very few antibodies. Furthermore, experimentally contaminated penicillin given according to the same schedule caused IgE antibody formation against the penicilloyl moiety, while pure penicillin did not. These findings were explained by the weak immunogenicity of isologous penicilloylated serum albumin in rabbits both regarding the IgE and the IgG/IgM antibody formation compared to the immunogenicity of heterologous bovine serum albumin similarly penicilloylated.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 511363     DOI: 10.1007/bf01659783

Source DB:  PubMed          Journal:  Infection        ISSN: 0300-8126            Impact factor:   3.553


  12 in total

1.  Antigens in penicillin allergy. IV. Induction of IgE antibody response in mice after daily treatment with contaminated but not with pure penicillin.

Authors:  A Kristofferson; S Ahlstedt; E Hall
Journal:  Int Arch Allergy Appl Immunol       Date:  1979

2.  Formation of homocytotropic antibodies with penicilloyl specificity in the rabbit.

Authors:  A K Rodell; S Ahlstedt; T K Olsson; P O Svärd
Journal:  Int Arch Allergy Appl Immunol       Date:  1976

3.  Antigens in penicillin allergy. III. Antigen and antibody levels in mice treated with pure and contaminated penicillins.

Authors:  S Ahlstedt; A Kristofferson; E Pettersson
Journal:  Int Arch Allergy Appl Immunol       Date:  1979

4.  A penicilloylated protein impurity as a source of allergy to benzylpenicillin and 6-aminopenicillanic acid.

Authors:  F R Batchelor; J M Dewdney; J G Feinberg; R D Weston
Journal:  Lancet       Date:  1967-06-03       Impact factor: 79.321

5.  A search for high molecular impurities in penicillin G.

Authors:  H Ottens; E de Haan; C H Sengers
Journal:  Int Arch Allergy Appl Immunol       Date:  1971

6.  Nature and extent of penicillin side-reactions, with particular reference to fatalities from anaphylactic shock.

Authors:  O Idsoe; T Guthe; R R Willcox; A L de Weck
Journal:  Bull World Health Organ       Date:  1968       Impact factor: 9.408

7.  On the proteinaceous impurity of penicillin.

Authors:  H L Weidenmüller; W Ziegler
Journal:  Arzneimittelforschung       Date:  1970-04

8.  The binding properties of rabbit antibodies against various penicillins as studied by immunoprecipitation, indirect haemagglutination and radiometric immunoassay.

Authors:  S Ahlstedt; A Kristoffersson; E Pettersson; P O Svärd
Journal:  Int Arch Allergy Appl Immunol       Date:  1976

9.  Antigens in penicillin allergy. I. A radioimmunoassay for detection of penicilloylated protein contaminants in penicillin preparations.

Authors:  A Kristofferson; S Ahlstedt; E Pettersson; P O Svärd
Journal:  Int Arch Allergy Appl Immunol       Date:  1977

10.  Studies on the mechanism of the formation of the penicillin antigen. III. The N-(D-alpha-benzylpenicilloyl) group as an antigenic determinant responsible for hypersensitivity to penicillin G.

Authors:  B B LEVINE; Z OVARY
Journal:  J Exp Med       Date:  1961-12-01       Impact factor: 14.307

View more
  2 in total

1.  Bacampicillin and ampicillin in urinary tract infections: a double-blind comparison of efficacy and tolerance.

Authors:  K H Müller-Ehrenberg; G Müller
Journal:  Infection       Date:  1979       Impact factor: 3.553

Review 2.  Studies on aminopenicillin developments. Proceedings of a symposium. Concluding remarks.

Authors:  T Bergan
Journal:  Infection       Date:  1979       Impact factor: 3.553

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.